Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

References

• Miller T Mapping the Global Muslim Population: A Report on the Size and Distribution of the World’s Muslim Population Washington, DC Pew Research Center 2009
   Google Scholar
• International Diabetes Federation Diabetes Atlas 2011 5th ed Brussels, Belgium International Diabetes Federation 2011
   Google Scholar
• Rauf Sheikh Abdul Muslim Way of Life New Delhi, India Taj Company 1984
   Google Scholar
• Rashed AH The fast of Ramadan Br Med J 1992 304 521 522 1559053
   PubMed Web of Science ®Google Scholar
• Sheikh A Gatrad AR Caring for Muslim Patients Oxford UK Radcliffe Medical Press 2000
   Google Scholar
• Cryer PE Davis SN Shamoon H Hypoglycemia in diabetes Diabetes Care 2003 26 1902 1912 12766131
   PubMed Web of Science ®Google Scholar
• Cahill GFJr Starvation in man N Engl J Med 1970 282 668 675 4915800
   PubMedGoogle Scholar
• UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 352 837 853 9742976
   PubMed Web of Science ®Google Scholar
• Zammitt NN Frier BM Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities Diabetes Care 2005 12 2948 2961 16306561
   PubMed Web of Science ®Google Scholar
• Bailey CJ Day C Hypoglycaemia: a limiting factor Br J Diabetes Vasc Dis 2010 10 2 4
   Google Scholar
• Miller CD Phillips LS Ziemer DC Gallina DL Cook CB El-Kebbi IM Hypoglycemia in patients with type 2 diabetes Arch Intern Med 2001 161 1653 1659 11434798
   PubMed Web of Science ®Google Scholar
• Salti I Bénard E Detournay B EPIDIAR study group A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study Diabetes Care 2004 27 2306 2311 15451892
   PubMed Web of Science ®Google Scholar
• Hajek P Myers K Dhanji AR West O McRobbie H Weight change during and after Ramadan fasting J Public Health (Oxf) 11 13 2011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Aravind SR Tayeb K Ismail SB Hypoglycemia in sulphonylurea- treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study Curr Med Res Opin 2011 27 1237 1242 21506631
   PubMed Web of Science ®Google Scholar
• Uysal AR Erdogan MF Sahin G Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan Diabetes Care 1998 21 2033 2034 9802768
   PubMed Web of Science ®Google Scholar
• Laajam MA Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control East Afr Med J 1990 67 732 736 2282897
   PubMed Web of Science ®Google Scholar
• Belkhadir J el-Ghomari H Klocker N Muslims with non-insulin-dependent diabetes fasting during Ramadan: treatment with glibenclamide Br Med J 1993 307 292 295 8374375
   PubMed Web of Science ®Google Scholar
• Katibi IA Akande AA Bojuwoye BJ Blood sugar control among fasting Muslims with type 2 diabetes mellitus in Ilorin Niger J Med 2001 10 132 134 11806014
   PubMedGoogle Scholar
• Akhan G Kutluhan S Koyuncuoglu HR Is there any change in stroke incidence during Ramadan? Acta Neurol Scand 2000 101 259 261 10770523
   PubMed Web of Science ®Google Scholar
• Del Prato S Felton A-M Munro N Improving glucose management: ten steps to get more patients with type 2 diabetes to goal. Recommendations from the Global Partnership for Effective Diabetes Management Int J Clin Pract 2005 59 1345 1355 16236091
   PubMed Web of Science ®Google Scholar
• Beshyah SA Fasting during the month of Ramadan for people with diabetes: Medicine and Fiqh united at last Ibnosina J Med Biomed Sci 2009 1 58 60
   Google Scholar
• National Institute for Clinical Excellence Type 2 Diabetes: The Management of Type 2 Diabetes. Clinical Guideline 87 London, UK National Institute for Clinical Excellence 2009
   Google Scholar
• Mojaddidi M Hassanein M Malik R Ramadan and diabetes: evidence-based guidelines Prescriber 2006 17 38 41
   Google Scholar
• AlMaatouq MA Manual of Diabetes Practice Milton Keynes, UK AuthorHouse Publishing 2010
   Google Scholar
• Bravis V Hui E Salih S Mehar S Hassanein M Devendra D Ramadan Education and Awareness in Diabetes (READ) program for Muslims with type 2 diabetes who fast during Ramadan Diabet Med 2010 27 327 331 20536496
   PubMed Web of Science ®Google Scholar
• Turner RC Cull CA Frighi V Holman RR Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 1999 281 2005 2012 10359389
   PubMed Web of Science ®Google Scholar
• Van de Laar FA Lucassen PL Akkermans RP Van de Lisdonk EH Rutten GE Van Weel C Alpha-glucosidase inhibitors for type 2 diabetes mellitus Cochrane Database Syst Rev 2005 2 CD003639 15846673
   PubMed Web of Science ®Google Scholar
• Defronzo RA Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 2009 58 773 795 19336687
   PubMed Web of Science ®Google Scholar
• Del Prato S Pulizzi N The place of sulfonylureas in the therapy for type 2 diabetes mellitus Metabolism 2006 55 Suppl 1 S20 S27 16631807
   PubMed Web of Science ®Google Scholar
• Mayfield JA White RD Insulin therapy for type 2 diabetes: rescue, augmentation and replacement of beta-cell function Am Fam Physician 2004 70 489 500 15317436
   PubMed Web of Science ®Google Scholar
• Nathan DM Buse JB Davidson MB Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 2004 49 1711 1721 16802130
   PubMed Web of Science ®Google Scholar
• de Grauw WJ van de Lisdonk EH van Gerwen WH van den Hoogen HJ van Weel C Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life? Br J Gen Pract 2001 51 527 532 11462311
   PubMed Web of Science ®Google Scholar
• Drucker DJ Nauck MA The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidylpeptidase-4 inhibitors in type 2 diabetes Lancet 2006 368 1696 1705 17098089
   PubMed Web of Science ®Google Scholar
• Younk LM Mikeladze M Davis SN Pramlintide and the treatment of diabetes: a review of the data since its introduction Expert Opin Pharmacother 2011 12 1439 1451 21564002
   PubMed Web of Science ®Google Scholar
• Bailey CJ Day C SGLT2 inhibitors: glucuretic treatment for type 2 diabetes Br J Diabetes Vasc Dis 2010 10 193 199
   Google Scholar
• Bailey CJ Turner RC Metformin N Engl J Med 1996 334 574 579 8569826
   PubMed Web of Science ®Google Scholar
• Retnakaran R Zinman B Thiazolidinediones and clinical outcomes in type 2 diabetes Lancet 2009 373 2088 2090 19501899
   PubMed Web of Science ®Google Scholar
• Devendra D Gohel B Bravis V Vildagliptin therapy and hypoglycemia in Muslim type 2 diabetes patients during Ramadan Int J Clin Pract 2009 63 1446 1450 19678856
   PubMed Web of Science ®Google Scholar
• Al Sifri S Basiounny A Echtay A The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial Int J Clin Pract 2011 65 1132 1140 21951832
   PubMed Web of Science ®Google Scholar
• Buse JB Rosenstock J Sesti G Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) Lancet 2009 374 39 47 19515413
   PubMed Web of Science ®Google Scholar
• Mafauzy M Repaglinide vs glibenclamide treatment of type 2 diabetes during Ramadan fasting Diabetes Res Clin Pract 2002 58 45 53 12161056
   PubMed Web of Science ®Google Scholar
• Anwar A Azmi KN Hamidon BB Khalid BA An open-label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan Med J Malaysia 2006 61 28 35 16708731
   PubMedGoogle Scholar
• Belkhadir J el Ghomari H Klocker N Mikou A Nasciri M Sabri M Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide Br Med J 1993 307 292 295 8374375
   PubMed Web of Science ®Google Scholar
• van Staa T Abenhaim L Monette J Rates of hypoglycemia in users of sulfonylureas J Clin Epidemiol 1997 50 735 741 9250272
   PubMed Web of Science ®Google Scholar
• Sari R Balci MK Akbas SH Avci B The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan Endocr Res 2004 30 169 177 15473127
   PubMed Web of Science ®Google Scholar
• Cesur M Corapcioglu D Gursoy A A comparison of glycemic effects of glimepiride, repaglinide and insulin glargine in type 2 diabetes mellitus during Ramadan fasting Diabetes Res Clin Pract 2007 75 141 147 16815586
   PubMed Web of Science ®Google Scholar
• Riddle MC Rosenstock J Gerich J The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 2003 26 3080 3086 14578243
   PubMed Web of Science ®Google Scholar
• Haak T Tiengo A Draeger E Suntum M Waldha W Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes Diabetes Obes Metab 2005 7 56 64 15642076
   PubMed Web of Science ®Google Scholar
• Ilag LL Kerr L Malone JK Tan MH Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison Clin Ther 2007 29 1254 1270
   Web of Science ®Google Scholar
• Janka HU Plewe G Riddle MC Kliebe-Frisch C Schweitzer MA Yki-Jarvinen H Comparison of basal insulin added to oral agents vs twice-daily premixed insulin as initial insulin therapy for type 2 diabetes Diabetes Care 2005 28 254 259 15677775
   PubMed Web of Science ®Google Scholar
• Swinnen S Hoekstra AJ Devris H Insulin therapy for type 2 diabetes Diabetes Care 2009 32 Suppl 2 S253 S259 19875560
   PubMed Web of Science ®Google Scholar
• Mattoo V Milicevic Z Malone JK Ramadan Study Group A comparison of insulin lispro mix 25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan Diabetes Res Clin Pract 2003 59 137 143 12560163
   PubMed Web of Science ®Google Scholar
• Hui E Bravis V Salih S Hassanein M Devendra D Comparison of Humalog Mix 50 with human insulin mix 30 in type 2 diabetes patients during Ramadan Int J Clin Pract 2010 64 1095 1099 20337752
   PubMed Web of Science ®Google Scholar
• Al-Arouj M Assaad-Khalil S Buse J Recommendations for management of diabetes during Ramadan: Update 2010 Diabetes Care 2010 33 1895 1902 20668157
   PubMed Web of Science ®Google Scholar
• Goenka N Thomas S Shaikh S Morrisey J Patel V Providing diabetes care to Arab migrants in the UK: cultural and clinical aspects Br J Diabetes Vasc Dis 2007 7 283 286
   Google Scholar
• Karamat MA Syed A Hanif W Review of diabetes management and guidelines during Ramadan J R Soc Med 2010 103 139 147 20382905
   PubMed Web of Science ®Google Scholar
• Ahmed MH Abdu TAM Diabetes and Ramadan: an update on use of glycemic therapies during fasting Ann Saudi Med 2010 31 402 406 21727749
   PubMed Web of Science ®Google Scholar